• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体:在人类癌症中的作用。

Epidermal growth factor receptor: Role in human cancer.

作者信息

Rajaram Prashanth, Chandra Poornima, Ticku Smriti, Pallavi B K, Rudresh K B, Mansabdar Poorva

机构信息

Department of Oral and Maxillofacial Surgery, V. S. Dental College and Hospital, Bangalore, Karnataka, India.

Department of Oral Medicine and Radiology, Rajarajeswari Dental College and Hospital, Bangalore, Karnataka, India.

出版信息

Indian J Dent Res. 2017 Nov-Dec;28(6):687-694. doi: 10.4103/ijdr.IJDR_534_16.

DOI:10.4103/ijdr.IJDR_534_16
PMID:29256471
Abstract

Cells are constantly exposed to various external stimuli which regulate the growth and survival of the cells. The signal transduction from the external environment to the interior of the cell is carried out by cell surface or transmembrane receptors. Epidermal growth factor receptor (EGFR) is a type I receptor tyrosine kinase and along with its ligands, EGFR is involved in the regulation of multiple cellular pathways. EGFR and its signaling pathway have been studied extensively for the biological and pathophysiological role in health and disease. There is enough evidence to suggest that EGFR is involved in the pathogenesis and progression of various cancers. This review discusses the structural anatomy and physiology of EGFR and its ligands, the role of EGFR in cancer and EGFR-targeted therapy.

摘要

细胞不断受到各种外部刺激,这些刺激调节着细胞的生长和存活。从外部环境到细胞内部的信号转导是由细胞表面或跨膜受体进行的。表皮生长因子受体(EGFR)是一种I型受体酪氨酸激酶,与它的配体一起,EGFR参与多种细胞途径的调节。EGFR及其信号通路在健康和疾病中的生物学和病理生理学作用已得到广泛研究。有充分证据表明EGFR参与各种癌症的发病机制和进展。本综述讨论了EGFR及其配体的结构解剖和生理学、EGFR在癌症中的作用以及EGFR靶向治疗。

相似文献

1
Epidermal growth factor receptor: Role in human cancer.表皮生长因子受体:在人类癌症中的作用。
Indian J Dent Res. 2017 Nov-Dec;28(6):687-694. doi: 10.4103/ijdr.IJDR_534_16.
2
Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.G蛋白偶联受体与表皮生长因子受体信号通路之间的相互作用促进了头颈部鳞状细胞癌的生长和侵袭。
Cancer Res. 2006 Dec 15;66(24):11831-9. doi: 10.1158/0008-5472.CAN-06-2876.
3
Targeting epidermal growth factor receptor in head and neck cancer.靶向头颈部癌中的表皮生长因子受体
Head Neck. 2003 Jan;25(1):67-73. doi: 10.1002/hed.10224.
4
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.表皮生长因子受体酪氨酸激酶抑制剂作为潜在的癌症化学预防剂。
Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):657-66.
5
Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.靶向表皮生长因子受体信号通路治疗头颈癌。
Expert Rev Anticancer Ther. 2006 Sep;6(9):1179-93. doi: 10.1586/14737140.6.9.1179.
6
Epidermal growth factor family receptors and inhibitors: radiation response modulators.表皮生长因子家族受体与抑制剂:辐射反应调节剂
Semin Radiat Oncol. 2003 Jan;13(1):22-30. doi: 10.1053/srao.2003.50003.
7
Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.靶向表皮生长因子受体信号传导:肿瘤学的早期结果与未来趋势
Ann Med. 2003;35(5):327-36.
8
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.头颈部癌症中的表皮生长因子受体 (EGFR):作用及其治疗意义。
Radiat Oncol. 2006 May 2;1:11. doi: 10.1186/1748-717X-1-11.
9
Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas.针对气消化道癌中表皮生长因子受体的疗法。
JAMA. 2007 Jul 4;298(1):70-82. doi: 10.1001/jama.298.1.70.
10
Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.溶血磷脂酸诱导的鳞状细胞癌细胞增殖和迁移涉及表皮生长因子受体信号转活化。
Cancer Res. 2002 Nov 1;62(21):6329-36.

引用本文的文献

1
Research Progress on the Functional Regulation Mechanisms of ZKSCAN3.锌指蛋白3(ZKSCAN3)功能调控机制的研究进展
Biomolecules. 2025 Jul 14;15(7):1016. doi: 10.3390/biom15071016.
2
Immunohistochemical profiling of Bcl-2 and EGFR proteins in cervical carcinoma at a tertiary hospital in Ghana.加纳一家三级医院宫颈癌中Bcl-2和表皮生长因子受体(EGFR)蛋白的免疫组织化学分析
Niger Med J. 2025 Jun 16;66(2):575-585. doi: 10.71480/nmj.v66i2.713. eCollection 2025 Mar-Apr.
3
Evaluating the Effectiveness of Tyrosine Kinase Inhibitors on EGFR Mutations In Vitro.
评估酪氨酸激酶抑制剂对体外表皮生长因子受体(EGFR)突变的有效性。
Int J Mol Sci. 2025 Jun 26;26(13):6157. doi: 10.3390/ijms26136157.
4
Development of Traditional Chinese Medicine in combination with EGFR Inhibitors against Cancer.中药与表皮生长因子受体抑制剂联合用于抗癌的研究进展
J Cancer. 2025 Jun 5;16(8):2595-2612. doi: 10.7150/jca.109420. eCollection 2025.
5
Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment.调节肿瘤微环境:中药在改善肺癌治疗中的作用。
Open Life Sci. 2025 May 20;20(1):20251100. doi: 10.1515/biol-2025-1100. eCollection 2025.
6
Tumor microenvironment in squamous cell lung cancer - histological and immunohistochemical study.肺鳞状细胞癌的肿瘤微环境——组织学和免疫组织化学研究
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):153-161. doi: 10.47162/RJME.66.1.14.
7
IL-10-Directed Cancer Immunotherapy: Preclinical Advances, Clinical Insights, and Future Perspectives.白细胞介素-10导向的癌症免疫疗法:临床前进展、临床见解及未来展望
Cancers (Basel). 2025 Mar 17;17(6):1012. doi: 10.3390/cancers17061012.
8
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC.针对胰腺癌肿瘤微环境的纳米医学策略的广泛综述
Int J Nanomedicine. 2025 Mar 17;20:3379-3406. doi: 10.2147/IJN.S504503. eCollection 2025.
9
[ Turcz. alleviates antibiotic-associated diarrhea in mice by modulating gut microbiota structure and regulating the EGFR/PI3K/Akt signaling pathway].图尔奇通过调节肠道微生物群结构和调控表皮生长因子受体/磷脂酰肌醇-3-激酶/蛋白激酶B信号通路减轻小鼠抗生素相关性腹泻
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Feb 20;45(2):285-295. doi: 10.12122/j.issn.1673-4254.2025.02.09.
10
TFAP2A facilitates the metastasis and radioresistance of esophageal cancer by promoting EGFR transcription.TFAP2A通过促进表皮生长因子受体(EGFR)转录来促进食管癌的转移和放射抗性。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 18. doi: 10.1007/s00210-025-03848-y.